Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 24 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

18%

2 of 11 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (5)
P 1 (2)
P 2 (2)
P 3 (1)

Trial Status

Completed11
Unknown8
Recruiting2
Not Yet Recruiting2
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT06262009RecruitingPrimary

Dynamics of AMR Spread, Persistence and Evolution Between Humans, Animals and Their Environment

NCT04460313Not ApplicableRecruiting

Nasopharyngeal Carriage of S. Pneumoniae

NCT07013552Not ApplicableNot Yet Recruiting

Oritavancin for CIED Infections With MDR Gram-positive Cocci

NCT06583642Not Yet Recruiting

Antimicrobial Therapeutic Drug Monitoring During Lung Transplant Perioperative Phase

NCT06314399Completed

Predictive Factors Associated to Bile Cultures and Antibiogram Resistance in Patients with Laparoscopic Cholecystectomy

NCT03963297CompletedPrimary

Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination

NCT05551988Completed

Predictors of Foot Amputation in Diabetic Foot Ulcers

NCT05027893Not ApplicableUnknown

Complications After Lower Third Molar Surgery

NCT04926935Completed

Bloodstram Infections in ICU. Single Centre Observational Study.

NCT03061097Phase 1CompletedPrimary

Autologous Fecal Microbiota Transplantation to Prevent Antibiotic Resistant Bacteria Colonization

NCT04795518UnknownPrimary

The Pattern of Antibiotic Prescription for Children Among a Group of Pediatric Dentists.

NCT04107194Phase 3Unknown

Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.

NCT04593368Phase 2UnknownPrimary

Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT)

NCT03208725Unknown

Childhood Acute Illness and Nutrition Network

NCT03063437Phase 2CompletedPrimary

A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization

NCT04212403Not ApplicableCompleted

Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)

NCT04269174Unknown

The Utility of Biofire Filmarray in Evaluation of Entero Pathogens Triggers in Patients With Chronic Diarrhea

NCT03167398Phase 1CompletedPrimary

Fecal Microbiota Transplantation for Eradication of CRE

NCT03391674Not ApplicableWithdrawnPrimary

Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization

NCT03767283UnknownPrimary

Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae

Scroll to load more

Research Network

Activity Timeline